Yedlapudi, D., Xu, L., Luo, D., Marsh, G. B., Todi, S. V., & Dutta, A. K. (2019). Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia. Nature Portfolio.
Style de citation Chicago (17e éd.)Yedlapudi, Deepthi, Liping Xu, Dan Luo, Gregory B. Marsh, Sokol V. Todi, et Aloke K. Dutta. Targeting Alpha Synuclein and Amyloid Beta by a Multifunctional, Brain-penetrant Dopamine D2/D3 Agonist D-520: Potential Therapeutic Application in Parkinson’s Disease with Dementia. Nature Portfolio, 2019.
Style de citation MLA (8e éd.)Yedlapudi, Deepthi, et al. Targeting Alpha Synuclein and Amyloid Beta by a Multifunctional, Brain-penetrant Dopamine D2/D3 Agonist D-520: Potential Therapeutic Application in Parkinson’s Disease with Dementia. Nature Portfolio, 2019.